Key Takeaways:
- Corteva reported full-year 2025 GAAP net sales of $17.40 billion, up 3% year-over-year.
- Operating EBITDA reached $3.85 billion, while Operating EPS was $3.34 on a non-GAAP basis.
- Seed and Crop Protection both delivered organic growth, supported by new products and biologicals.
- Strong cash generation enabled over $1.5 billion returned to shareholders in 2025.
- Corteva refined its 2026 guidance, targeting operating EBITDA of $4.0–$4.2 billion.
Corteva Delivers Full-Year Growth Despite Mixed Market Conditions
Corteva, Inc. (NYSE: CTVA) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting growth across regions and continued demand for its seed and crop protection portfolios.
For full-year 2025, Corteva reported GAAP income from continuing operations of $1.20 billion, with earnings per share of $1.75. Net sales increased 3% year-over-year, while organic sales rose 4%, supported by gains in all regions. On a non-GAAP basis, operating EBITDA reached $3.85 billion, up 14% compared to 2024, and operating EPS increased 30% to $3.34.
Chuck Magro, Chief Executive Officer of Corteva, said the results reflected sustained execution across the business. “Our delivery of strong second-half and full-year results reflects continued demand for our differentiated technologies and disciplined execution across the company,” he said.
Corteva Performance by Segment
Seed Business Shows Strong Technology-Driven Gains
Corteva’s Seed segment delivered full-year net sales of $9.90 billion, up 4% year-over-year, with organic growth of 5%. Price and mix improved across all regions, led by North America and EMEA, reflecting demand for new technology offerings and increased licensing income. Volume growth was driven by expanded corn acreage in North America and Brazil, partially offset by lower soybean area in North America.
Segment operating EBITDA for Seed reached $2.64 billion, a 19% increase compared to 2024, supported by productivity improvements, market share gains, and reduced net royalty expense.
Crop Protection Sees Volume Growth Amid Pricing Pressure
The Crop Protection segment reported full-year net sales of $7.50 billion, up 2% year-over-year, with organic growth of 3%. Volume increased 5%, driven by demand for new products, herbicides, and biologicals. Pricing declined 2%, primarily due to competitive dynamics in Latin America, partially offset by price increases in North America.
Full-year segment operating EBITDA increased 6% to $1.35 billion, with productivity savings and volume growth offsetting price pressure and higher operating costs.
Corteva Advances Strategic and Financial Priorities
Separation Progress and Bayer Resolution
Corteva confirmed it remains on track to complete its planned separation in the second half of 2026, with several key milestones expected in the first half of 2026, including leadership appointments and regulatory filings.
During 2025, Corteva also finalized a comprehensive resolution with Bayer, providing multi-year clarity on technology access and licensing rights. The agreement accelerates Corteva’s path to royalty neutrality to 2026 and supports its long-term goal of achieving $1 billion in net royalty income by 2035.
Corteva Outlook for 2026
Looking ahead, Corteva refined its 2026 guidance and expects operating EBITDA of $4.0 to $4.2 billion and operating EPS of $3.45 to $3.70. The company noted that while commodity prices and farmer margins remain under pressure, global crop demand and adoption of new technologies continue to support growth opportunities.
Read the entire financial results.
13 Comments